These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 32171380)
1. Using the Pharmaceutical Collection Database to identify patient adherence to oral hypoglycaemic medicines. Kharjul MD; Cameron C; Braund R J Prim Health Care; 2019 Sep; 11(3):265-274. PubMed ID: 32171380 [TBL] [Abstract][Full Text] [Related]
2. The influence of pharmacist-led adherence support on glycaemic control in people with type 2 diabetes. Kharjul M; Braund R; Green J Int J Clin Pharm; 2018 Apr; 40(2):354-359. PubMed ID: 29468528 [TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
4. Polypharmacy and oral antidiabetic treatment for type 2 diabetes characterised by drug class and patient characteristics: A Japanese database analysis. Horii T; Iwasawa M; Kabeya Y; Atuda K Sci Rep; 2019 Sep; 9(1):12992. PubMed ID: 31506542 [TBL] [Abstract][Full Text] [Related]
5. Adherence, Persistence, and Switching Among People Prescribed Sodium Glucose Co-transporter 2 Inhibitors: A Nationwide Retrospective Cohort Study. Ofori-Asenso R; Liew D; Lalic S; Mazidi M; Magliano DJ; Ademi Z; Bell JS; Ilomaki J Adv Ther; 2019 Nov; 36(11):3265-3278. PubMed ID: 31482509 [TBL] [Abstract][Full Text] [Related]
6. Oral antidiabetic therapy in a large Italian sample: drug supply and compliance for different therapeutic regimens. Vittorino Gaddi A; Benedetto D; Capello F; Di Pietro C; Cinconze E; Rossi E; De Sando V; Cevenini M; D'Alò G Public Health; 2014 Jan; 128(1):70-6. PubMed ID: 23969148 [TBL] [Abstract][Full Text] [Related]
7. Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care. White AJ; Kellar I; Prevost AT; Kinmonth AL; Sutton S; Canny M; Griffin SJ Prim Care Diabetes; 2012 Apr; 6(1):27-33. PubMed ID: 21840277 [TBL] [Abstract][Full Text] [Related]
8. One-year adherence to oral antihyperglycemic medication and risk prediction of patient outcomes for adults with diabetes mellitus: An observational study. Huber CA; Rapold R; Brüngger B; Reich O; Rosemann T Medicine (Baltimore); 2016 Jun; 95(26):e3994. PubMed ID: 27368004 [TBL] [Abstract][Full Text] [Related]
9. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic. Huang YM; Shiyanbola OO; Chan HY; Smith PD Postgrad Med; 2020 May; 132(4):328-336. PubMed ID: 32233892 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United Kingdom. Tunceli K; Iglay K; Zhao C; Brodovicz KG; Radican L Diabetes Res Clin Pract; 2015 Sep; 109(3):e27-31. PubMed ID: 26233933 [TBL] [Abstract][Full Text] [Related]
11. Adherence of patients with type 2 diabetes mellitus to medications: the role of risk preferences. Simon-Tuval T; Shmueli A; Harman-Boehm I Curr Med Res Opin; 2018 Feb; 34(2):345-351. PubMed ID: 29069921 [TBL] [Abstract][Full Text] [Related]
12. Dispensing patterns for antidiabetic agents in New Zealand: are the guidelines being followed? Murray P; Norris H; Metcalfe S; Betty B; Young V; Locke B N Z Med J; 2017 Nov; 130(1465):12-18. PubMed ID: 29121620 [TBL] [Abstract][Full Text] [Related]
13. Oral antidiabetic drug use and associated health outcomes in cancer patients. Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485 [TBL] [Abstract][Full Text] [Related]
14. The management of people with type 2 diabetes with hypoglycaemic agents in primary care: retrospective cohort study. Calvert MJ; McManus RJ; Freemantle N Fam Pract; 2007 Jun; 24(3):224-9. PubMed ID: 17488736 [TBL] [Abstract][Full Text] [Related]
15. Adherence to oral diabetes medications among users and nonusers of antipsychotic medication. Desai PR; Adeyemi AO; Richards KM; Lawson KA Psychiatr Serv; 2014 Feb; 65(2):215-20. PubMed ID: 24233254 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of community pharmacist-provided telephone interventions to improve adherence to hypertension and diabetes medications. Stanton-Robinson C; Al-Jumaili AA; Jackson A; Catney C; Veach S; Witry MJ J Am Pharm Assoc (2003); 2018; 58(4S):S120-S124. PubMed ID: 29891173 [TBL] [Abstract][Full Text] [Related]
17. Adherence to metformin monotherapy in people with type 2 diabetes mellitus in New Zealand. Horsburgh S; Barson D; Zeng J; Sharples K; Parkin L Diabetes Res Clin Pract; 2019 Dec; 158():107902. PubMed ID: 31672501 [TBL] [Abstract][Full Text] [Related]
18. Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care. Schernthaner G Diabet Med; 2010 Jul; 27(7):739-43. PubMed ID: 20636953 [TBL] [Abstract][Full Text] [Related]
19. Self-monitoring blood glucose test strip use with diabetes medicines in people with types 1 and 2 diabetes in New Zealand. Metcalfe S; Moodie P; Norris H; Rasiah D N Z Med J; 2014 Nov; 127(1406):48-62. PubMed ID: 25447249 [TBL] [Abstract][Full Text] [Related]
20. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review. Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]